Pancreatic Cancer Research

ResearcherUniversity of MichiganNo recent work listed

Mats E. Ljungman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1553-6695; OpenAlex author ID A5052545112; NIH RePORTER profile ID 1858113. Sources: OpenAlex.

Their work

Papers
14
Trials
0
Grants
2
Labs led
1
Collaborators
48
Papers, trials and grants by year

2011: 1 grant · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 4 papers · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 3 papers · 2023: 2 papers, 1 grant

Papers 14

  1. KMT2D links TGF-β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticity. Co-author DOI 10.1002/ijc.34528↗
  2. First-in-Class NADH/Ubiquinone Oxidoreductase Core Subunit S7 (NDUFS7) Antagonist for the Treatment of Pancreatic Cancer. Co-author DOI 10.1021/acsptsci.3c00069↗
  3. KDM6A Regulates Cell Plasticity and Pancreatic Cancer Progression by Noncanonical Activin Pathway. Co-author DOI 10.1016/j.jcmgh.2021.09.014↗
  4. Induction of Genes Implicated in Stress Response and Autophagy by a Novel Quinolin-8-yl-nicotinamide QN523 in Pancreatic Cancer. Co-author DOI 10.1021/acs.jmedchem.1c02207↗
  5. KDM6A Loss Recruits Tumor-Associated Neutrophils and Promotes Neutrophil Extracellular Trap Formation in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-22-0968↗
  6. The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress-Mediated Apoptosis in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-20-1540↗
  7. Discovery of Mitochondrial Transcription Inhibitors Active in Pancreatic Cancer Cells. Co-author DOI 10.1002/cmdc.202000494↗
  8. UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancer. Co-author DOI 10.1016/j.tranon.2020.100834↗
  9. Synthesis and mechanistic studies of quinolin-chlorobenzothioate derivatives with proteasome inhibitory activity in pancreatic cancer cell lines. Co-author DOI 10.1016/j.ejmech.2018.09.037↗
  10. Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1021/acs.jmedchem.7b01463↗
  11. Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci.insight.97422↗
  12. HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties. Co-author DOI 10.7554/elife.33947↗
  13. PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance. Co-author DOI 10.1101/gad.291021.116↗
  14. ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cells. Co-author DOI 10.1158/0008-5472.can-13-2289↗

Grants 2

  1. Targeting the RNA Exosome for Cancer Therapeutics R01CA213214↗
  2. Targeting ATDC with PARP inhibitors in pancreatic cancer R21CA150100↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nouri Neamati · 7 shared papers, 1 shared grant, 2018–2023 · strength 1.51
  2. Vaibhav Sahai · 1 shared grant, 2023 · strength 0.61
  3. Howard C. Crawford · 5 shared papers, 2016–2023 · strength 0.52
  4. Jiaqi Shi · 4 shared papers, 2018–2023 · strength 0.47
  5. Marina Pasca di Magliano · 4 shared papers, 2018–2023 · strength 0.47
  6. Zhujun Yi · 3 shared papers, 2022–2023 · strength 0.41
  7. Ding Xue · 2 shared papers, 2021–2023 · strength 0.34
  8. Yibin Xu · 2 shared papers, 2020–2023 · strength 0.31
  9. Jing Yang · 2 shared papers, 2022 · strength 0.27
  10. Yumei Gu · 2 shared papers, 2022–2023 · strength 0.26
  11. Yuting Kuang · 2 shared papers, 2018–2021 · strength 0.24
  12. Joyeeta Roy · 1 shared paper, 2023 · strength 0.20
  13. Yuting Kuang · 1 shared paper, 2022 · strength 0.15
  14. Amy Shiu Lee · 1 shared paper, 2021 · strength 0.13
  15. Soma Samanta · 1 shared paper, 2021 · strength 0.13
  16. Shuang Lu · 1 shared paper, 2023 · strength 0.13
  17. Chandan Kumar‐Sinha · 2 shared papers, 2018 · strength 0.13
  18. Theodore Steven Lawrence · 2 shared papers, 2014–2020 · strength 0.13
  19. Wen‐Ming Chen · 1 shared paper, 2020 · strength 0.11
  20. Christopher J. Halbrook · 2 shared papers, 2016–2018 · strength 0.11
  21. Shuai Hu · 1 shared paper, 2018 · strength 0.11
  22. Mario Sechi · 1 shared paper, 2018 · strength 0.11
  23. Diane M. Simeone · 2 shared papers, 2014–2018 · strength 0.10
  24. Alnawaz Rehemtulla · 1 shared paper, 2020 · strength 0.09
  25. Meredith Ann Morgan · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.